CAPA Management Audit Readiness
Verify your CAPA system drives real corrective action, not just paper closure
Overview
What's Inside
CAPA is the single most scrutinised quality subsystem during FDA inspections. Investigators evaluate whether corrective and preventive actions are initiated promptly, whether root cause analyses are thorough enough to identify the true source of the problem, and whether effectiveness checks prove the issue has been permanently resolved.
This checklist is built from real FDA 483 observation patterns targeting CAPA system weaknesses — including inadequate root cause investigations, missing effectiveness verification, failure to extend CAPAs to similar products or processes, and poor integration with management review. Each section maps common observations to root causes, recommended corrective actions, and the specific evidence investigators expect.
It also includes an investigator-readiness section with YES/NO/N/A audit questions covering CAPA initiation criteria, investigation thoroughness, timeliness metrics, effectiveness check methodology, and trending analysis — giving your team a structured self-assessment tool before an inspection arrives.
Why It Matters
CAPA effectiveness is the bellwether of your entire quality system. FDA investigators use CAPA performance to judge whether a site is in control. Repeat observations, inadequate root cause analysis, and missing effectiveness checks are among the most common 483 findings — and they signal systemic failures that escalate rapidly to warning letters.
What's Covered
Sections in this checklist
- CAPA initiation criteria and timeliness benchmarks
- Root cause analysis methodology and investigation depth
- Effectiveness check design and verification of recurrence prevention
- Extension of CAPAs to similar products, processes, and systems
- CAPA trending analysis and quality metrics
- Management review integration and escalation protocols
- Investigator-readiness audit questions with recommended evidence
- Root cause to CAPA mapping for common 483 observation themes
Who It's For
Target roles
Regulatory Basis
21 CFR 211.192, ICH Q10, FDA Compliance Program 7356.002
Download CAPA Management Audit Readiness
Enter your details once to unlock all Audit Hub resources. All future downloads are instant.
Related Checklists
Complaint Management Audit Readiness
End-to-end audit readiness checklist for pharmaceutical complaint management systems, covering complaint investigation thoroughness, root cause analysis, retain sample testing, CAPA linkage, and trending analysis aligned with FDA 483 focus areas.
Quality Risk Management Audit Readiness (ICH Q9)
Comprehensive 100-point QRM audit checklist spanning all six FDA systems plus documentation, training, complaint management, and continuous improvement — structured as Yes/No/NA self-assessment questions aligned with ICH Q9 and ICH Q10.
Document Management Audit Readiness
Comprehensive 150+ point audit checklist for pharmaceutical document management covering SOP governance, controlled document issuance, training and competency, QA oversight, data integrity and GDP compliance, retention and archiving, manufacturing and QC records, and policy governance.
Leucine is the first AI-native platform built for pharmaceutical manufacturing. It unifies quality management, regulatory compliance, and production operations into one intelligent system that powers your entire drug manufacturing lifecycle from raw materials to patient delivery.
